BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 2, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Lambrolizumab designated as breakthrough therapy by the FDA
April 26, 2013
BMS-986015 shows efficacy in a novel animal model of lymphoma
April 26, 2013
Dosing begins in phase I/II anal cancer study of ADXS-HPV
April 24, 2013
New prostate cancer vaccine is safe in patients
April 24, 2013
Roche develops interleukin-2 variant for cancer immunotherapy
April 23, 2013
Phase II study of BI-505 in multiple myeloma begins
April 22, 2013
NKTR-214 is significantly more efficacious in vivo compared to aldesleukin
April 22, 2013
Ablynx presents in vitro and in vivo data for novel anti-c-Met Nanobody
April 18, 2013
IMCgp-100 well tolerated in patients with advanced melanoma
April 18, 2013
Clinical data for AMP-224 presented at AACR meeting
April 18, 2013
Previous
1
2
…
675
676
677
678
679
680
681
682
683
…
1010
1011
Next
RSS